Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System

NCT03880955 is registered in ClinicalTrials.gov with Stryker Trauma and Extremities as lead sponsor.

NCT NCT03880955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03880955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System
Lead sponsor
Stryker Trauma and Extremities
Phase
Observational
Overall status
Terminated
Start date
June 25, 2019
Completion date
December 13, 2023
Enrollment
102 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

shoulder arthroplasty